The new Republican chairman of the Senate Finance Committee squashed Democratic hopes Wednesday of passing a proposal to allow the government to negotiate directly with drug companies to lower prescription drug prices.
The new Republican chairman of the Senate Finance Committee squashed Democratic hopes Wednesday of passing a proposal to allow the government to negotiate directly with drug companies to lower prescription drug prices.